Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: bill  mccausland  successful  recover  relapse  prevention  self  help  addiction  author  interview  pancreatic  cancer  detection  awareness  treatment  disease  health  multivu  8213751  cancer  health  research  treatment  disease  2017  aacr  fda  multivu  8155051  mental  health  study  23andme  bipolar  attention  healthcare  treatment  multivu  8150951  bloodcenter  health  healthcare  thrombocytopenia  blood  treatment  multivu  8126851  health  healthcare  disease  rare  day  awareness  medical  hemophilia  research  multivu  8046151  photo  social  media  profile  health  overweight  appearance  improvement  treatment  multivu  7962051  health  healthcare  webmd  baby  child  medicine  treatment  operation  doctor  multivu  7579754  astellas  innovation  debate  2015  digital  hospital  personalised  medicine  health  healthcare  multivu  7432051  phenogen  sciences  brevagen  brevagenplus  cancer  predictive  risk  assessment  test  women  health  multivu  7337351  alzheimers  dementia  mental  health  disease  college  american  pathologists  meeting  2014  cap14  cancer  molecular  genetic  testing  pathology  medicine  multivu  7270051 
Search // genetic
Results 1-12 of 27 for ' genetic ' (0 seconds)
The workbook addresses several concepts and starts with the prevention of relapse. The major part of the workbook is how to develop support systems for maintaining recovery that contribute to successful recovery. The text shows many elements that contribute to addiction. It goes into detail about the genetic aspects of addiction. There is also a segment of how executive functioning of the brain can get impaired with addiction that compromises judgment, impulse control, and the ability to organize. But these impairments can be temporary with practicing having good judgment and impulse control, since new neuropathways can develop with exercising these functions. The stages of recovery and change are reviewed as well as the twelve steps of Alcoholics Anonymous and Narcotics Anonymous. One chapter is dedicated to powerlessness and unmanageability. At the end of each chapter, there are references for the reader to consult that have been used for the content of the workbook chapters. Find out more at https://www.amazon.com/Successful-Recovery-Relapse-Prevention-McCausland-ebook/dp/B079648R6X Non-fiction, self-help
Categories // Miscellaneous  Howto and DIY 
Added: 45 days ago by cosproductions
Runtime: 3m41s | Views: 2 | Comments: 0
Not yet rated
 

 

 

Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers. “The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.” To view the multimedia release go to: https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
Categories // Miscellaneous 
Added: 428 days ago by MultiVuVideos
Runtime: 2m0s | Views: 4 | Comments: 2
Not yet rated
 

 

 

Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Categories // Miscellaneous 
Added: 555 days ago by MultiVuVideos
Runtime: 1m0s | Views: 7 | Comments: 3
Not yet rated
 

 

 

23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions. “We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.” To view the multimedia release go to: https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Categories // Miscellaneous 
Added: 598 days ago by MultiVuVideos
Runtime: 1m0s | Views: 5 | Comments: 1
Not yet rated
 

 

 

BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology. BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes. To view the multimedia release go to: https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Categories // Miscellaneous 
Added: 635 days ago by MultiVuVideos
Runtime: 1m57s | Views: 5 | Comments: 1
Not yet rated
 

 

 

Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments. To view the multimedia release go to: https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
Categories // Miscellaneous 
Added: 753 days ago by MultiVuVideos
Runtime: 1m42s | Views: 8 | Comments: 0
Not yet rated
 

 

 

Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best. Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo. To view the multimedia release go to: http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Categories // Miscellaneous 
Added: 878 days ago by MultiVuVideos
Runtime: 3m40s | Views: 60 | Comments: 1
Not yet rated
 

 

 

Today, WebMD released Path to a Breakthrough, a five-part original video series developed in partnership with Robin Roberts and her independent production company, Rock’n Robin Productions. Through compelling patient stories and insights from medical experts, Path to a Breakthrough sheds light on how medical innovations, including Precision Medicine, Immunotherapy, and Biologics, are providing doctors with powerful new tools to treat disease, alleviate symptoms, and in some cases, reverse the course of debilitating illness. In this extraordinary new series, WebMD and Roberts share the stories of Cara, a 4-year-old girl who lost, then regained her ability to walk from the clues hidden in her genetic makeup; Trevor, a man diagnosed with stage IV Lymphoma in the prime of his life, and the doctor who helped him harness his own immune system for a nontoxic cancer treatment; Kevin, whose pain from dirt bike racing injuries was nothing compared to the excruciating pain of Rheumatoid Arthritis; Falisha, whose life-changing diagnosis of Multiple Sclerosis was alleviated by biologics; and Rebecca, whose debilitating Psoriasis led to blindness. To view the multimedia release go to: http://www.multivu.com/players/English/7579754-webmd-path-to-a-breakthrough/
Categories // Miscellaneous 
Added: 962 days ago by MultiVuVideos
Runtime: 0m56s | Views: 247 | Comments: 0
Not yet rated
 

 

 

Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain. As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
Categories // Science and Technology 
Added: 1513 days ago by MultiVuVideos
Runtime: 2m5s | Views: 264 | Comments: 2
Not yet rated
 

 

 

Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Categories // People and Blog  Business 
Added: 1629 days ago by MultiVuVideos
Runtime: 2m12s | Views: 399 | Comments: 2
Not yet rated
 

 

 

Persistent deterioration of short-term memory, progressive confusion and disorientation and frequent agitation are characteristic of Alzheimer’s disease. We have been told that it is largely genetic but that there are some things that can be done to reduce the severity or how early the onset is. We can’t change our genetic makeup but we can change our behavior to help mitigate the effects of this type of dementia. These are all things we can accomplish with a little determination and planning. http://youtu.be/9eMrmVMuAa0
Categories // Family  People and Blog 
Added: 1643 days ago by gmsarticles
Runtime: 3m-0s | Views: 329 | Comments: 2
Not yet rated
 

 

 

New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
Categories // Science and Technology 
Added: 1683 days ago by MultiVuVideos
Runtime: 5m19s | Views: 299 | Comments: 0
Not yet rated
 

 

 

Page 1 of 3  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2019 ClipMoon.com. All rights reserved.